1211PHyperprogression during immuno-checkpoint inhibitors (ICIs): A clinically significant problem?. (23rd October 2018) - Farè, E; Sdao, S; Damian, S; Cresta, S; Del Vecchio, M; Di Bartolomeo, M; Di Guardo, L A; Duca, M; Indini, A; Necchi, A; Niger, M; Prisciandaro, M; et al.